Pyrosequencing Reveals Restricted Patterns of CD8 T Cell Escape-Associated Compensatory Mutations in Simian Immunodeficiency Virus
|
|
- Nickolas Bridges
- 5 years ago
- Views:
Transcription
1 JOURNAL OF VIROLOGY, Dec. 2011, p Vol. 85, No X/11/$12.00 doi: /jvi Copyright 2011, American Society for Microbiology. All Rights Reserved. Pyrosequencing Reveals Restricted Patterns of CD8 T Cell Escape-Associated Compensatory Mutations in Simian Immunodeficiency Virus Benjamin J. Burwitz, 1 Jonah B. Sacha, 2,3 Jason S. Reed, 2,3 Laura P. Newman, 1 Francesca A. Norante, 1 Benjamin N. Bimber, 4 Nancy A. Wilson, 1 David I. Watkins, 1 and David H. O Connor 1,4 * Department of Pathology, University of Wisconsin-Madison, Madison, Wisconsin ; Vaccine & Gene Therapy Institute 2 and Oregon National Primate Research Center, 3 Oregon Health & Science University, Portland, Oregon 97006; and Wisconsin National Primate Research Center, Madison, Wisconsin Received 12 July 2011/Accepted 10 October 2011 CD8 T cells play a major role in the containment of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication. CD8 T cell-driven variations in conserved regions under functional constraints result in diminished viral replicative capacity. While compensatory mutations outside an epitope can restore replicative capacity, the kinetics with which they arise remains unknown. Additionally, certain patterns of linked mutations associated with CD8 T cell epitope escape in these highly conserved regions may lead to variable levels of viral fitness. Here, we used pyrosequencing to investigate the kinetics and patterns of mutations surrounding the Mamu-A1*00101-bound Gag CM9 CD8 T cell epitope. We obtained more than 400 reads for each sequencing time point, allowing us to confidently detect the emergence of viral variants bearing escape mutations with frequencies as low as 1% of the circulating virus. With this level of detail, we demonstrate that compensatory mutations generally arise concomitantly with Gag CM9 escape mutations. We observed distinct patterns of linked flanking mutations, most of which were found downstream of Gag CM9. Our data indicate that, whereas Gag CM9 escape is much more complex that previously appreciated, it occurs in a coordinated fashion, with very specific patterns of flanking mutations required for immune evasion. This is the first detailed report of the ontogeny of compensatory mutations that allow CD8 T cell epitope escape in infected individuals. Human immunodeficiency virus (HIV) strains, like those of other retroviruses, are genetically diverse within and between hosts. This diversity increases the fitness of HIV through evasion of host immune responses. Indeed, the evolution of HIV over time shows evidence of adaptation in response to CD8 T cell responses restricted by HLA-A and HLA-B alleles (6, 9, 13, 14). Determination of an optimal set of HIV-derived CD8 T cell antigens and deployment of these antigens in an appropriate vector are major goals of HIV vaccine research. Thus, understanding how host cellular immune responses drive viral sequence evolution is crucial for rational vaccine design. Certain major histocompatibility complex (MHC) class I- bound epitopes found in individuals infected with HIV or simian immunodeficiency virus (SIV) show a limited capacity for variation, with escape mutations often only occurring late (if at all) in chronic infection (8, 15, 20). These epitopes are found in regions of the virus that are conserved due to structural or functional constraints (8, 15, 20). However, compensatory mutations found near a subset of these epitopes enable intraepitope variation and maintenance of viral replication (4, * Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, University of Wisconsin Madison, 555 Science Dr., Madison, WI Phone: (608) Fax: (608) doconnor@primate.wisc.edu. B.J.B. and J.B.S. contributed equally to the work. Supplemental material for this article may be found at Published ahead of print on 12 October , 10, 21, 22, 26). The assortment of compensatory mutations found in these regions may affect viral variation within the epitope as well as viral fitness. A comprehensive analysis of the kinetics and patterns of epitope and compensatory mutations has yet to be undertaken. Here, we utilized pyrosequencing to examine the ontogeny of compensatory mutations flanking the well-described, conserved Mamu-A1*00101-bound epitope Gag CM9. Previous studies identified an association between Gag CM9 escape and two compensatory mutations: Gag I161V and Gag I206V (7, 20). We expand on those studies by describing a diverse set of putative compensatory mutations not previously characterized and show that these novel mutations arise in an array of patterns and are associated with different amino acid substitutions at Gag T182, the second position of the Gag CM9 epitope. Furthermore, we observed strong clonal associations between Gag T182 mutants and flanking compensatory mutations, even when these mutations were rare within the viral quasispecies. Cumulatively, our data suggest that viral escape from Gag CM9-specific CD8 T cells occurs only via discrete pathways involving coordinated amino acid substitutions both within and outside the viral epitope. MATERIALS AND METHODS Animals and vaccinations. The Indian rhesus macaques used in this study were all previously described in other publications (Table 1). Some of the animals were vaccinated before infection with SIVmac239 as previously described. Animals were infected with the cloned virus SIVmac239. The Wisconsin National 13088
2 VOL. 85, 2011 PYROSEQUENCING REVEALS COMPENSATORY MUTATION PATTERNS Animal TABLE 1. Indian rhesus macaques used in this study Gag CM9 escape mutation with highest frequency Vaccination a Reference r00044 T182A DNA/Ad5 (Gag/Tat/Rev/Nef) 25 r00060 T182A DNA/Ad5 (Gag/Tat/Rev/Nef) 25 r95114 T182A 1 r97113 T182I DNA/Ad5 (Gag/Tat/Rev/Nef) 25 r95058 T182I DNA/MVA (Gag) 2 rh1937 T182I 17 r00014 T182S/C DNA/Ad5 (Gag/Tat/Rev/Nef) 25 rh2127 (r31157) T182S/C DNA/rMVA (Tat/Rev/Nef/Gag 24 CM9/Tat SL8) r00045 T182S/L 25 r a Ad5, adenovirus type 5; MVA, modified vaccinia Ankara virus; rmva, recombinant MVA. Primate Research Center (University of Wisconsin, Madison, WI) maintained the SIV-infected macaques in accordance with experimental protocols approved by the University of Wisconsin Research Animal Resources Center review committee. SIV sequencing. Cell-free plasma was obtained from EDTA-treated anticoagulated whole blood by using Ficoll-Paque Plus (GE Healthcare Bioscience) and density centrifugation. Plasma was frozen at 80 C until the time of viral RNA extraction. Viral RNA in the plasma was isolated using a QIAamp MinElute virus spin kit (Qiagen, Valencia, CA) according to the manufacturer s instructions. Viral RNA was reverse transcribed (RT) and amplified using a SuperScript III One-Step RT-PCR system with Platinum Taq DNA Polymerase High Fidelity (Invitrogen, Carlsbad, CA) and MID-tagged primers (454; Life Sciences, Branford, CT) spanning Gag amino acid residues 155 to 253 (see Table S1 in the supplemental material). The RT-PCR conditions were as follows: 50 C for 15 min; 94 C for 2 min; 40 cycles of 94 C for 15 s, 58 C for 30 s, and 68 C for 50 s; and 68 C for 5 min. Following RT-PCR, DNA in each sample was purified using two rounds of Ampure XP magnetic bead separation (Agencourt, Bendigo, Victoria, Australia) (bead/pcr product ratio, 0.6:1). Samples were quantified using Quant-iT high-sensitivity (HS) reagents (Invitrogen, Carlsbad, CA). Amplicons were pooled at equimolar ratios, and the final library was diluted to copies/ l. Emulsion PCR (empcr) was performed using 1.5 copies/bead and a GS Junior Titanium empcr kit (Lib-A) per the instructions of the manufacturer (Roche, Indianapolis, IN). Enriched DNA beads ( ) were sequenced using a Roche/454 GS Junior system. SIV sequence analysis. Pyrosequencing flowgram data were processed using Roche Amplicon Variant Analyzer (AVA) software. Within Roche AVA, flowgram reads were aligned to the reference SIVmac239 sequence (GenBank accession no. M33262), and then identical read results were assembled into groups. Manual editing was performed using CodonCode alignment software (Codon- Code Corp., Dedham, MA) only when homopolymeric regions differed by 1 nucleotide and resulted in frameshifts. Improved base-calling using Roche AVA software compensates for base addition artifacts in homopolymeric regions, and manual editing was kept to a minimum. Pyrosequencing read groups generated by Roche AVA were analyzed using customized BLAST-based software (written by B. N. Bimber) to identify and translate positions of difference between the experimental data and the reference SIVmac239 genome (3). The source code for this pipeline can be obtained from a subversion repository ( /custommodules/sequenceanalysis). Instructions for accessing this repository, including a guest password, can be found at the following URL: The pipeline itself has been integrated into the LabKey software platform as the SequenceAnalysis module, which provides a graphical, Web-based platform to initiate analysis pipelines and view results. LabKey is a free, open-source software package available at For each individual time point, only mutations present in more than 1% of total reads were considered to represent data above the background. Generation of SIV Gag 3D models. Five separate models of the N-terminal 283-residue fragment of the immature SIVmac239 Gag polyprotein were generated using the Geno3D automatic molecular modeling tool ( /htm/index.php) and model PDB 1L6N (homologous HIV sequence) as a template. Three-dimensional (3D) structures were visualized using PyMol freeware ( Biochemical bonds and distances between amino acids were separately investigated using PyMol for all five models. RESULTS Mamu-A1*00101-positive rhesus macaques infected with SIVmac239 consistently mount an immunodominant CD8 T-cell response to the Gag CM9 epitope. However, immune escape within this epitope does not typically occur until late in chronic infection. Gag CM9 lies within a highly conserved portion of the Gag protein. Nevertheless, escape mutations eventually arise at position Gag T182 (position 2 of the Gag CM9 epitope) in many Mamu-A1*00101-positive animals, and escape has been associated with two flanking compensatory mutations: Gag I161V and Gag I206V (7, 20). Escape within the Gag CM9 epitope has also been observed to occur in the absence of either Gag I161V or Gag I206V, however, suggesting that other compensatory mutations may exist (7, 20). In order to comprehensively characterize the kinetics and patterns by which compensatory mutations arise, we selected nine SIVmac239-infected Mamu-A1*00101-positive rhesus macaques and examined viral evolution occurring within and flanking the Gag CM9 epitope by Roche/454 pyrosequencing. These animals were selected based on the availability of longitudinal samples and the results of previous Sangerbased sequencing showing escape at position T182 of the Gag protein. Specifically, we stratified our animals into three groups based on T182 escape: (i) T182A; (ii) T182I; and (iii) T182S/C/L (Table 1). Six of the Mamu-A1*00101-positive animals had been vaccinated prior to SIVmac239 infection, although this did not appear to affect the timing or route of Gag CM9 escape. Finally, to verify the sensitivity of our approach, we analyzed the Gag sequence from one Mamu- A1*00101-negative rhesus macaque (r02120; Fig. 1A). We were unable to detect viral variations at above 0.6% of total reads at any position within Gag CM9 in the sequences obtained from this animal (Fig. 1A). We therefore set the limit of detection of viral variation in this study at 1% of total sequencing reads. We longitudinally examined three rhesus macaques (r95114, r95058, and r00014) over the course of acute and chronic SIV infections. Time-of-death Sanger sequencing showed that each of these animals harbored one of the three major types of Gag T182 escape: (i) T182A; (ii) T182I; or (iii) T182S/C (Table 1). Strikingly, we observed an emergence of the T182A escape mutation that was coincident with an S242T mutation in r95114 in the absence of the previously described I161V or I206V mutations (Fig. 1B). We detected the I161V and I206V compensatory mutations, but they emerged only after the establishment of virus harboring the T182A and S242T mutations (Fig. 1B). Interestingly, we found a downstream S242T mutation at late time points in chronic infection in two additional rhesus macaques with the T182A escape mutation (r00044 and r00060; see Fig. S1 in the supplemental material and /WNPRC_Laboratories/oconnor/public/publications/begin.view?). This S242T mutation had been observed previously in SIVmac239- infected, Mamu-A1*00101-positive rhesus macaques (7), but its potential role in Gag CM9 escape is not clear. We detected sim-
3 13090 BURWITZ ET AL. J. VIROL. FIG. 1. Consensus sequences of the Gag CM9 region in rhesus macaques. The Gag CM9 region from Mamu-A1*00101-positive rhesus macaques was pyrosequenced. (A) r02120; (B) r95114; (C) r95058; (D) rh2127. Each consensus sequence contains each mutation(s) present in 1% or more of total reads. Changes are indicated by the use of the single-letter amino acid code for substitutions where only one residue with a change was found at a given position with a frequency 1%. All other changes are indicated with the letter X; the frequencies of mixed amino acids are listed below the corresponding positions. Nonsynonymous mutations are colored according to prevalence (indicated by the color key on the right). Positions where nonsynonymous mutations were observed are listed across the top. Yellow highlighting denotes the nine amino acids comprising the CD8 T cell epitope Gag CM9.
4 VOL. 85, 2011 PYROSEQUENCING REVEALS COMPENSATORY MUTATION PATTERNS ilar frequencies of the T182A escape mutation and the S242T mutation at all time points of sequencing for r95114, a situation analogous to the similar frequencies of T182A and I206V observed in r00044 and r00060 (Fig. 1B; see also Fig. S1 in the supplemental material). The association between escape at position 2 of the Gag CM9 epitope (T182A) and the S242T mutation indicated that a more complex system of compensatory mutations may exist in SIVmac239-infected, Mamu-A1* positive animals than had been previously appreciated. Furthermore, Gag CM9 position 2 (T182) escape mutations are predominantly alanine, isoleucine, or cysteine substitutions, as shown by historical Sanger sequencing (7, 16). We therefore hypothesized that differing amino acid substitutions present at Gag CM9 position 2 (T182) would be associated with different patterns of flanking mutations. We observed a pattern of mutations associated with the T182I escape mutation in r95058 that was different from the patterns seen with viruses harboring the T182A escape mutation in r95114 (Fig. 1C). The coincident I206V and S242T mutations that occurred with the emergence of the T182A escape mutation were found in fewer than 18% of the total sequence reads during the emergence of the T182I escape mutation in r Instead, we found a distinct pattern of flanking mutations, with V243A and D244E mutations found at frequencies similar to the T182I escape frequency (Fig. 1C). However, upon further inspection of two additional rhesus macaques with the T182I escape mutation, we again discovered the downstream S242T mutation (see Fig. S2 in the supplemental material and /labkey/project/wnprc/wnprc_laboratories/oconnor/public /publications/begin.view?). These data indicate the existence of multiple pathways that allow Gag CM9 escape. Finally, we assessed the flanking mutations associated with the T182S/C escape mutation found in animal rh2127. We again found a pattern of flanking mutations that was unique compared to those assessed in animals r95114 and r We found similar frequencies of the T182S/C escape mutation and the S242T mutation, as seen with the pattern observed in r95114 (Fig. 1 B and D). However, we discovered an absence of the I206V and V243A mutations, common in animals with T182A or T182I escape mutations, respectively, in the sequences at all time points (Fig. 1D). To confirm our results, we sequenced virus from an additional animal with the T182S/C escape mutation (see Fig. S3 in the supplemental material and /labkey/project/wnprc/wnprc_laboratories/oconnor/public /publications/begin.view?). We found a similar pattern of Gag CM9 flanking mutations, with low frequencies of I206V and an absence of V243A. We observed a particularly complex pattern of flanking mutations accompanying Gag CM9 escape in animal r00045 (Fig. 2). We found multiple Gag CM9 escape variants that began with a predominating T182S escape mutation and shifted over time to a T182L escape mutation (Fig. 2). Intriguingly, this shift within the viral quasispecies corresponded to changes in the frequencies of mutations P221Q and A222T (Fig. 2). Our alignment of consensus sequences in investigations of the Gag CM9 region indicated that novel compensatory mutations may exist and that particular patterns of mutations in the capsid protein may be required to allow viral escape. However, to interpret the importance of these mutations for Gag CM9 escape, we needed to better understand their clonal associations within the viral quasispecies. To this end, we measured the frequency of each of several unique amino acid sequences within our virus population (Fig. 3). We found that greater than 80% of viral genomes in r95114 with a T182A escape mutation also harbored the S242T mutation (Fig. 3A). We observed similar viral variants in rh2127, where the T182S and T182C escape mutations were also clonally associated with the S242T mutation (Fig. 3C). These data support our conclusion that the S242T mutation allows Gag CM9 escape. The emergence of the T182I escape variant in r95058 occurred at between 47 and 67 weeks postinfection (wpi), and we did not have viral RNA samples from this time interval to examine (Fig. 3B). Therefore, no flanking mutations associated with the emergence of T182I escape could be identified. However, we did observe mutations on viral genomes that were rarely linked to the T182I escape mutation (Fig. 3B). The I206V mutation was rarely linked to either the S242T mutation or the M250T mutation, again suggesting that specific patterns of mutations downstream of the Gag CM9 escape sequence are required for viral replication. Given the complexity of the T182S/C/L escape mutations in r00045, we were particularly eager to assess clonal associations between the Gag CM9 escape sequence and flanking mutations. The T182A escape mutation was clonally associated with the I206V and I161V mutations at 60 wpi, supporting our previous finding observed in animals with the T182A escape mutation (Fig. 1B and 4; see also Fig. S1 in the supplemental material). Additionally, the T182S escape mutation was clonally associated with the unique A222T mutation at this same time point (Fig. 4). We were surprised to find that none of the viruses with the T182S escape mutation contained the I206V mutation (Fig. 2). Interestingly, we discovered a clonal association between the emerging T182L escape mutation and the P221Q mutation that began at 119 wpi (Fig. 4). These two mutations continued to rise in frequency over time within the viral quasispecies and were linked at all subsequent time points. We complemented our analysis of Gag CM9 escape by generating three-dimensional models of viral variants that we detected in the viral quasispecies of different animals. The region of the capsid protein encompassing the Gag CM9 epitope has been shown to play a role in multiple events, including capsid multimerization, capsid maturation, and uncoating of the capsid following cell entry, within the SIV life cycle (11, 12, 19). Therefore, compensatory mutations allowing viral escape presumably restore the structure and function of the capsid protein. We were surprised to find that S242, which mutated in many animals showing Gag CM9 escape, was spatially closer to T182 than the previously described I206V compensatory mutation (Fig. 5). However, there were no direct bonds found between T182 and the common S242, V243, and D244 amino acids associated with escape (Fig. 5). This is not an entirely surprising result, given that the previously described I206V compensatory mutation, which has been shown to restore viral fitness in vitro, also shares no direct bonds with T182. Additionally, we were unable to detect biochemical as-
5 13092 BURWITZ ET AL. J. VIROL. Downloaded from FIG. 2. Consensus sequence of the Gag CM9 region in rhesus macaque r The Gag CM9 region from Mamu-A1*001-positive rhesus macaque r00045 was pyrosequenced. Each consensus sequence contains each mutation(s) present in 1% or more of total reads. Changes are indicated by the use of the single-letter amino acid code for substitutions where only one residue with a change was found at a given position with a frequency 1%. All other changes are indicated with the letter X; the frequencies of mixed amino acids are listed below the corresponding positions. Nonsynonymous mutations are colored according to prevalence (indicated by the color key on the right). Positions where nonsynonymous mutations were observed are listed across the top. Yellow highlighting denotes the nine amino acids comprising the CD8 T cell epitope Gag CM9. sociations between T182 and any of the flanking mutations we observed in this study (data not shown). DISCUSSION Gag CM9 lies within the capsid protein of SIVmac239 (20). Specifically, the epitope is found in a stretch of 20 amino acids that is highly conserved in all retroviruses, indicating the structural importance of this region. Therefore, the common T182 escape mutation within this epitope is hindered by structural and functional constraints (21). Two mutations flanking Gag CM9, I161V and I206V, allow epitope escape by restoring viral fitness (7). We show here that Gag CM9 escape is associated with much more complex patterns of flanking mutations (Fig. 6). Specifically, we discovered distinct patterns of mutations associated with different types of Gag CM9 escape. The T182A escape mutation was accompanied by high-frequency I161V and I206V mutations (Fig. 6A). In contrast, viruses with the T182I or T182S/C/L escape mutation lacked high-frequency I161V and I206V mutations (Fig. 6B and C). Viruses with the T182I escape mutation were associated with both V243A and D244E, whereas viruses with T182S/C/L were associated with D244E only (Fig. 6B and C). Interestingly, in both cases where the predominant virus population exhibited Gag CM9 escape but neither I206V nor S242T, we discovered a pair of mutations at positions D244 and M250. Therefore, it is possible that the combination of these two mutations may substitute for a single compensatory mutation, such as I206V. These flanking mutations often arise contemporaneously on the same viral genomes as Gag CM9 escape variants and represent putative novel compensatory mutations. Indeed, the on September 28, 2018 by guest
6 VOL. 85, 2011 PYROSEQUENCING REVEALS COMPENSATORY MUTATION PATTERNS Downloaded from FIG. 3. Linkage of Gag CM9 escape and flanking mutations in rhesus macaques. (A) r95114; (B) r95058; (C) rh2127. Each table shows the amino acid substitution within Gag CM9 (left, bold). Positions where nonsynonymous mutations were observed are listed (top left). Time points postinfection are listed (top right). The frequency of each pattern of linked mutations within the viral quasispecies is listed (bottom right). on September 28, 2018 by guest importance of the I206V compensatory mutation to SIVmac239 viral fitness has been previously demonstrated (7), and we found clonal associations between the T182A escape mutation and the I206V compensatory mutation in our study. Similar clonal associations between the T182 escape mutation and the downstream S242T mutation strongly suggest that this is a novel compensatory mutation. Animals with the T182 escape mutation and without either the I206V or S242T mutation (r95058 and r00045) exhibited differing patterns of flanking mutations, indicating that the system of compensatory mutations associated with Gag CM9 escape is highly complex. Additionally, we observed a single instance where the T182A escape mutation was not accompanied by flanking mutations (r97113 at 98 wpi). Therefore, it is likely that additional Gag CM9-associated compensatory mutations exist outside the region of Gag we examined. We also examined the kinetics of compensatory mutations in relation to Gag CM9 escape in multiple Mamu- A1*00101-positive rhesus macaques. It has been hypothesized that delays in the emergence of Gag CM9 variants are due to a requirement for a secondary compensatory mutation, making the combination of events highly unlikely to occur simultaneously. Indeed, the probability of two amino acid substitutions occurring simultaneously within the SIV genome, assuming that nucleotide mutations at each position are equally likely and a conservative reverse transcriptase error
7 13094 BURWITZ ET AL. J. VIROL. FIG. 4. Linkage of Gag CM9 escape and flanking mutations in rhesus macaque r Each table shows the amino acid substitution within Gag CM9 (left, bold). Positions where nonsynonymous mutations were observed are listed (top left). Time points postinfection are listed (top right). The frequency of each pattern of linked mutations within the viral quasispecies is listed (bottom right). rate of ,is (18). However, there are additional conditions that must be met for viruses with Gag CM9 escape to amass within the host. Our results support previous findings showing that the number of nonsynonymous mutations allowed at T182 of Gag CM9 is limited, making the simultaneous occurrence of Gag CM9 escape and a compensatory mutation even more unlikely. Additionally, both necessary mutations must occur in a virus that FIG. 5. Three-dimensional representation of the crystal structure of SIVmac239 capsid. This SIVmac239 capsid model was generated using Geno3D and HIV-1 protein databank file 1L6N as a template. (A) Distances between the carboxyl group of amino acid T182 and the carboxyl groups of amino acids I206 and S242. Yellow dotted lines represent distances in angstroms (Å). (B) No hydrogen bonds exist between amino acid T182 and amino acid S242, V243, or D244. Green dashed lines represent hydrogen bonds.
8 VOL. 85, 2011 PYROSEQUENCING REVEALS COMPENSATORY MUTATION PATTERNS FIG. 6. Summary of nonsynonymous flanking mutations associated with Gag CM9 escape. Blue boxes indicate amino acid positions where the majority ( 50%) of viral genomes carried a nonsynonymous mutation at the final time point of sequencing. Yellow highlighting denotes the nine amino acids comprising the CD8 T cell epitope Gag CM9. is replication competent, avoids host immunity, and produces infectious particles. Given these conditions, the accumulation of viruses harboring a Gag CM9 escape mutation is highly rare. The diverse patterns of flanking compensatory mutations observed in this study, along with the distinct clonal associations we detected in animals with Gag CM9 escape, indicate that a second level of constraint may impede viral escape in this epitope. It is possible not only that reverse transcriptase must make errors within two specific codons in a relatively short period of time but also that these errors must generate specific amino acid substitutions which together are capable of retaining viral fitness. This idea is supported by recently published random matrix theory analyses of HIV-1 clade B Gag sequences, which concluded that groups of specific amino acid positions within Gag mutate in a highly interdependent manner (5), presumably to maintain viral fitness while avoiding host immune responses. That innovative approach to sequence analysis has revealed a higher order of conservation within Gag. Interestingly, Gag CM9 and large sections of the flanking sequences we examined lie within the SIVmac239 p27 protein in a region homologous to what was defined by Dahirel et al. as Sector 3, the most highly conserved portion of Gag, according to random matrix theory analysis (5). However, a more thorough investigation into structural changes caused by combinations of mutations within the capsid protein is required to elucidate the limitations of Gag CM9 escape, and further work studying the replicative capacity of engineered SIVmac239 viruses would be required to confirm our putative novel compensatory mutations. Given that viral fitness is the consequence of a delicate interplay between sequence evolution and host immune pressure, understanding the delayed escape within Gag CM9 may also require sequencing of full SIV genomes. Since sequence divergence within multiple epitopes can compound losses in viral fitness, viral variation may be restrained to a limited number of epitopes. Thus, epitope escape that occurs at a cost to the virus in the form of limiting its fitness must take place early in infection, making escape within structurally or functionally constrained epitopes more difficult. Indeed, longitudinal genome-wide studies may begin to reveal the restrictions placed on sequence evolution in HIV and SIV. ACKNOWLEDGMENTS We thank Austin Hughes for invaluable advice in determining Gag CM9 escape probabilities. We also thank Roger Wiseman, Julie Karl, and Simon Lank for maintaining the Roche/454 GS Junior sequencing instrument, as well as for troubleshooting advice. This publication was made possible by grant P51 RR from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison; the research was conducted at a facility constructed with support from Research Facilities Improvement Program (grant RR ). Additional funding was provided by grants 1R01AI084787, R01AI A1, and R33AI from the National Institutes of Health (NIH). REFERENCES 1. Allen, T. M., et al Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: Allen, T. M., et al Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J. Immunol. 164: Bimber, B. N., et al Ultradeep pyrosequencing detects complex patterns of CD8 T-lymphocyte escape in simian immunodeficiency virusinfected macaques. J. Virol. 83: Crawford, H., et al Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA- B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81: Dahirel, V., et al Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc. Natl. Acad. Sci. U. S. A. 108: Dilernia, D. A., et al HLA-driven convergence of HIV-1 viral subtypes B and F toward the adaptation to immune responses in human populations. PLoS One 3:e3429.
9 13096 BURWITZ ET AL. J. VIROL. 7. Friedrich, T. C., et al Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-t-lymphocyte response. J. Virol. 78: Honeyborne, I., et al HLA-Cw*03-restricted CD8 T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation. J. Virol. 84: Kawashima, Y., et al Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: Kelleher, A. D., et al Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193: Lanman, J., et al Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J. Mol. Biol. 325: Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407: Matthews, P. C., et al HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering. J. Virol. 83: Ngandu, N. K., C. Seoighe, and K. Scheffler Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission. Virol. J. 6: Nietfield, W., et al Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J. Immunol. 154: O Connor, D. H., et al A dominant role for CD8 -T-lymphocyte selection in simian immunodeficiency virus sequence variation. J. Virol. 78: O Connor, D. H., et al Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-t-lymphocyte responses. J. Virol. 77: Overbaugh, J., and C. R. Bangham Selection forces and constraints on retroviral sequence variation. Science 292: Owens, C. M., et al Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J. Virol. 78: Peyerl, F. W., et al Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope. J. Virol. 77: Peyerl, F. W., et al Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. J. Virol. 78: Schneidewind, A., et al Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA- B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82: Valentine, L. E., et al Infection with escaped virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu- B*08-positive macaques. J. Virol. 83: Vogel, T. U., et al Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J. Virol. 77: Wilson, N. A., et al Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80: Yeh, W. W., et al Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations. J. Virol. 80: Downloaded from on September 28, 2018 by guest
Whole-Genome Characterization of Human and Simian Immunodeficiency Virus Intrahost Diversity by Ultradeep Pyrosequencing
JOURNAL OF VIROLOGY, Nov. 2010, p. 12087 12092 Vol. 84, No. 22 0022-538X/10/$12.00 doi:10.1128/jvi.01378-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Whole-Genome Characterization
More informationReceived 19 September 2007/Accepted 21 November 2007
JOURNAL OF VIROLOGY, Feb. 2008, p. 1723 1738 Vol. 82, No. 4 0022-538X/08/$08.00 0 doi:10.1128/jvi.02084-07 Copyright 2008, American Society for Microbiology. All Rights Reserved. Patterns of CD8 Immunodominance
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationOn an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures
HIV-1 evolution in response to immune selection pressures BISC 441 guest lecture Zabrina Brumme, Ph.D. Assistant Professor, Faculty of Health Sciences Simon Fraser University http://www3.niaid.nih.gov/topics/hivaids/understanding/biology/structure.htm
More informationSupplementary Figures. Supplementary Figure 1. Treatment schematic of SIV infection and ARV and PP therapies.
Supplementary Figures Supplementary Figure 1. Treatment schematic of SIV infection and ARV and PP therapies. Supplementary Figure 2. SIV replication and CD4 + T cell count. (A) Log SIVmac239 copies/ml
More informationMina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia
Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia AIDSvaccine conference, 14 th September 2011 IMGT HLA database July 2011 >5000 class
More informationLecture 11. Immunology and disease: parasite antigenic diversity
Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html
More informationNEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar
NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock
More informationPatterns of hemagglutinin evolution and the epidemiology of influenza
2 8 US Annual Mortality Rate All causes Infectious Disease Patterns of hemagglutinin evolution and the epidemiology of influenza DIMACS Working Group on Genetics and Evolution of Pathogens, 25 Nov 3 Deaths
More informationTo test the possible source of the HBV infection outside the study family, we searched the Genbank
Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),
More informationDETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester
DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview
More informationGOVX-B11: A Clade B HIV Vaccine for the Developed World
GeoVax Labs, Inc. 19 Lake Park Drive Suite 3 Atlanta, GA 3 (678) 384-72 GOVX-B11: A Clade B HIV Vaccine for the Developed World Executive summary: GOVX-B11 is a Clade B HIV vaccine targeted for use in
More informationSupporting Information
Supporting Information Sui et al..7/pnas.997 Pre-CLP CM9 LA9 SL Tat# Pol Vif % Tetramer + CD + CD + Vac+IL- +IL- Vac Fig. S. Frequencies of six different CD + CD + Mamu-A*-tetramer + cells were measured
More informationChronic HIV-1 Infection Frequently Fails to Protect against Superinfection
Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human
More informationCitation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside
UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based
More informationReceived 10 November 2010/Accepted 13 January 2011
JOURNAL OF VIROLOGY, Apr. 2011, p. 3250 3261 Vol. 85, No. 7 0022-538X/11/$12.00 doi:10.1128/jvi.02355-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Transcriptionally Abundant
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationGrade Level: Grades 9-12 Estimated Time Allotment Part 1: One 50- minute class period Part 2: One 50- minute class period
The History of Vaccines Lesson Plan: Viruses and Evolution Overview and Purpose: The purpose of this lesson is to prepare students for exploring the biological basis of vaccines. Students will explore
More informationThe Swarm: Causes and consequences of HIV quasispecies diversity
The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability
More informationSUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish
SUPPLEMENTARY INFOATION Divergent TLR7/9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS-virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford,
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationEvolution of influenza
Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal
More informationHow HIV Causes Disease Prof. Bruce D. Walker
How HIV Causes Disease Howard Hughes Medical Institute Massachusetts General Hospital Harvard Medical School 1 The global AIDS crisis 60 million infections 20 million deaths 2 3 The screen versions of
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationDEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED
DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps
More information7.014 Problem Set 7 Solutions
MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable
More informationViral CTL Escape Mutants Are Generated in Lymph Nodes and Subsequently Become Fixed in Plasma and Rectal Mucosa during Acute SIV Infection of Macaques
Viral CTL Escape Mutants Are Generated in Lymph Nodes and Subsequently Become Fixed in Plasma and Rectal Mucosa during Acute SIV Infection of Macaques Thomas Howerton Vanderford, Emory University Chelsea
More informationJulianne Edwards. Retroviruses. Spring 2010
Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationVIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON
VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION
More informationCo-evolution of host and pathogen: HIV as a model. Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL
Co-evolution of host and pathogen: HIV as a model Can Keşmir Theoretical Biology/Bioinformatics Utrecht University, NL c.kesmir@bio.uu.nl Outline Does HIV adapt to monomorphic human molecules? Polymorphic
More informationTreatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques
SUPPORTING INFORMATION FOR: Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques Lia Vassena, 1,2 Huiyi Miao, 1 Raffaello Cimbro,
More informationFigure S1. Schematic presentation of genomic replication of idsiv after transfection and infection. After transfection of idsiv plasmid DNA into 293T
Figure S1. Schematic presentation of genomic replication of idsiv after transfection and infection. After transfection of idsiv plasmid DNA into 293T cells, the RNA genomes with all modifications are generated
More informationRajesh Kannangai Phone: ; Fax: ; *Corresponding author
Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal
More informationLecture 2: Virology. I. Background
Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationAIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria
AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel
More informationUnderstanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute
Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought
More informationcure research HIV & AIDS
Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationReceived 25 April 2002/Accepted 21 May 2002
JOURNAL OF VIROLOGY, Sept. 2002, p. 8757 8768 Vol. 76, No. 17 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.17.8757 8768.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Clustering
More informationPredicting the Impact of a Nonsterilizing Vaccine against Human Immunodeficiency Virus
JOURNAL OF VIROLOGY, Oct. 2004, p. 11340 11351 Vol. 78, No. 20 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.20.11340 11351.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Predicting
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature14008 Supplementary Figure 1. Sequence alignment of A/little yellow-shouldered bat/guatemala/060/2010 (H17N10) polymerase with that of human strain A/Victoria/3/75(H3N2). The secondary
More informationMutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey
Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC
More informationCurrent Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study
Note: I have added some clarifying comments to the slides -- please click on Comments under View to see them. Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a
More informationVIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer
VIRAL TITER COUNTS The best methods of measuring infectious lentiviral titer FLUORESCENCE CYCLES qpcr of Viral RNA SUMMARY Viral vectors are now routinely used for gene transduction in a wide variety of
More informationHIV 101: Fundamentals of HIV Infection
HIV 101: Fundamentals of HIV Infection David H. Spach, MD Professor of Medicine University of Washington Seattle, Washington Learning Objectives After attending this presentation, learners will be able
More informationDevelopment of a Universal T Cell Vaccine. Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom
Development of a Universal T Cell Vaccine Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom Development of HIV-1 vaccines Induction of cell-mediated responses Immunogens
More informationProtein Structure and Computational Biology, Good morning and welcome!
Protein Structure and Computational Biology, 27617 Good morning and welcome! Program 9.00-9.30 Introduction to the course 9.30-9.40 Break 9.40-10.00 Introduction to influenza a recurring case story 10.00-10.10
More informationWORLD HEALTH ORGANIZATION. Smallpox eradication: destruction of Variola virus stocks
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB111/5 111th Session 23 December 2002 Provisional agenda item 5.3 Smallpox eradication: destruction of Variola virus stocks Report by the Secretariat 1. The WHO
More informationAntigen Recognition by T cells
Antigen Recognition by T cells TCR only recognize foreign Ags displayed on cell surface These Ags can derive from pathogens, which replicate within cells or from pathogens or their products that cells
More informationSUPPLEMENTARY INFORMATION
Supplementary Notes 1: accuracy of prediction algorithms for peptide binding affinities to HLA and Mamu alleles For each HLA and Mamu allele we have analyzed the accuracy of four predictive algorithms
More informationDATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.
Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter
More informationReliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants
Pandit and de Boer Retrovirology 2014, 11:56 RESEARCH Open Access Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants
More informationClinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2007, p. 550 578 Vol. 20, No. 4 0893-8512/07/$08.00 0 doi:10.1128/cmr.00017-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Clinical Significance
More informationLESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
More informationLESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication
DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit
More informationOriginally published as:
Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681
More informationPrevention of infection 2 : immunisation. How infection influences the host : viruses. Peter
Prevention of infection 2 : immunisation How infection influences the host : viruses Peter Balfe, p.balfe@bham.ac.uk @pbalfeuk Let s have some LO s just for fun 1. Define the Immune response to viruses,
More informationAn Evolutionary Story about HIV
An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst
More informationnumbe r Done by Corrected by Doctor
numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic
More informationRAISON D ETRE OF THE IMMUNE SYSTEM:
RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Acquired Immunity Innate immunity: (Antigen nonspecific) defense
More informationSelection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection
JOURNAL OF VIROLOGY, Oct. 2006, p. 9519 9529 Vol. 80, No. 19 0022-538X/06/$08.00 0 doi:10.1128/jvi.00575-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Selection on the Human
More informationT cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces
JVI Accepts, published online ahead of print on 13 May 2009 J. Virol. doi:10.1128/jvi.00114-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationLecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background
Lecture 6 Burr BIO 4353/6345 HIV/AIDS Andrew McMichael seminar: Background Tetramer staining of T cells (CTL s) 1. Vβ 19: There are 52 T cell receptor (TCR) Vβ gene segments in germ line DNA (See following
More informationModeling the Antigenic Evolution of Influenza Viruses from Sequences
Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.
More informationIdentification of hepatitis B virus DNA reverse transcriptase variants associated with partial response to entecavir
Title Identification of hepatitis B virus DNA reverse transcriptase variants associated with partial response to entecavir Author(s) Wong, DKH; Fung, JYY; Lai, CL; Yuen, RMF Citation Hong Kong Medical
More informationCharacterizing intra-host influenza virus populations to predict emergence
Characterizing intra-host influenza virus populations to predict emergence June 12, 2012 Forum on Microbial Threats Washington, DC Elodie Ghedin Center for Vaccine Research Dept. Computational & Systems
More informationHIV-1 acute infection: evidence for selection?
HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig
More informationIs an HIV Vaccine Possible?
304 BJID 2009; 13 (August) Is an HIV Vaccine Possible? Nancy A. Wilson 1,2 and David I. Watkins 1,2 1 Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison; 2 Wisconsin National
More informationHIV-1 Viral Load Real Time (RG)
-1 Viral Load Real Time (RG) Real Time RT-PCR type 1 RNA quantification assay MSP Reg. pending Valdense 3616. 11700. Montevideo. Uruguay. phone (598) 2 336 83 01. Fax (598) 2 336 71 60. Info@atgen.com.uy
More informationHOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS
HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute
More informationVirus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef DAVID T. EVANS 1, DAVID H. O CONNOR 1, PEICHENG JING 1, JOHN L. DZURIS 2, JOHN
More informationEMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)
AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,
More informationBioinformation by Biomedical Informatics Publishing Group
Predicted RNA secondary structures for the conserved regions in dengue virus Pallavi Somvanshi*, Prahlad Kishore Seth Bioinformatics Centre, Biotech Park, Sector G, Jankipuram, Lucknow 226021, Uttar Pradesh,
More informationon October 4, 2018 by guest
JCM Accepts, published online ahead of print on 3 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.01249-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Title: Performance of
More informationCD8 + T Cells from SIV Elite Controller Macaques Recognize Mamu-B*08-Bound Epitopes and Select for Widespread Viral Variation
CD8 + T Cells from SIV Elite Controller Macaques Recognize Mamu-B*08-Bound Epitopes and Select for Widespread Viral Variation John T. Loffredo 1. *, Thomas C. Friedrich 1., Enrique J. León 1, Jason J.
More informationImmune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa
African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length
More informationHuman Genome Complexity, Viruses & Genetic Variability
Human Genome Complexity, Viruses & Genetic Variability (Learning Objectives) Learn the types of DNA sequences present in the Human Genome other than genes coding for functional proteins. Review what you
More informationThe Role of B Cell Follicles in HIV Replication and Persistence
The Role of B Cell ollicles in HIV Replication and Persistence Elizabeth Connick, M.D. Professor of Medicine Chief, Division of Infectious Diseases University of Arizona July 17, 2016 IAS 2016 Towards
More informationCS229 Final Project Report. Predicting Epitopes for MHC Molecules
CS229 Final Project Report Predicting Epitopes for MHC Molecules Xueheng Zhao, Shanshan Tuo Biomedical informatics program Stanford University Abstract Major Histocompatibility Complex (MHC) plays a key
More informationFONS Nové sekvenační technologie vklinickédiagnostice?
FONS 2010 Nové sekvenační technologie vklinickédiagnostice? Sekvenování amplikonů Sequence capture Celogenomové sekvenování FONS 2010 Sekvenování amplikonů Amplicon sequencing - amplicon sequencing enables
More informationChapter 6- An Introduction to Viruses*
Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses
More informationSupplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T
More informationFrom Mosquitos to Humans: Genetic evolution of Zika Virus
Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical
More informationReceived 2 August 2002/Accepted 13 August 2002
JOURNAL OF VIROLOGY, Nov. 2002, p. 11623 11636 Vol. 76, No. 22 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.22.11623 11636.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Escape
More informationGoing Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.
Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials
More informationViral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP
Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal
More informationExploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein
Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through
More informationAlper Sarikaya 1, Michael Correll 2, Jorge M. Dinis 1, David H. O Connor 1,3, and Michael Gleicher 1
Alper Sarikaya 1, Michael Correll 2, Jorge M. Dinis 1, David H. O Connor 1,3, and Michael Gleicher 1 1 University of Wisconsin-Madison 2 University of Washington 3 Wisconsin National Primate Center @yelperalp
More informationSupplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood
Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial
More informationVirus Genetic Diversity
Virus Genetic Diversity Jin-Ching Lee, Ph.D. 李 jclee@kmu.edu.tw http://jclee.dlearn.kmu.edu.t jclee.dlearn.kmu.edu.tw TEL: 2369 Office: N1024 Faculty of Biotechnology Kaohsiung Medical University Outline
More informationA VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART
BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)
More informationReceived 4 August 2005/Accepted 7 December 2005
JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination
More informationHigh Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure
More informationIntroduction. In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology.
Introduction In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology. - Genomics: fasten antigen discovery for complex pathogens
More informationReassortment of influenza A virus genes linked to PB1 polymerase gene
International Congress Series 1263 (2004) 714 718 Reassortment of influenza A virus genes linked to PB1 polymerase gene Jean C. Downie* www.ics-elsevier.com Centre for Infectious Diseases and Microbiology,
More informationIntroduction retroposon
17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element
More informationCOMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1
Journal of Cell and Tissue Research Vol. 10(3) 2359-2364 (2010) ISSN: 0973-0028 (Available online at www.tcrjournals.com) Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN
More information